These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 22438871)

  • 1. Identification and pathway analysis of microRNAs with no previous involvement in breast cancer.
    Romero-Cordoba S; Rodriguez-Cuevas S; Rebollar-Vega R; Quintanar-Jurado V; Maffuz-Aziz A; Jimenez-Sanchez G; Bautista-Piña V; Arellano-Llamas R; Hidalgo-Miranda A
    PLoS One; 2012; 7(3):e31904. PubMed ID: 22438871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer and microRNAs: therapeutic impact.
    Iorio MV; Casalini P; Piovan C; Braccioli L; Tagliabue E
    Breast; 2011 Oct; 20 Suppl 3():S63-70. PubMed ID: 22015296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
    McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
    J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of ERBB family mRNA expression in breast carcinomas.
    Bièche I; Onody P; Tozlu S; Driouch K; Vidaud M; Lidereau R
    Int J Cancer; 2003 Sep; 106(5):758-65. PubMed ID: 12866037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
    Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
    Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of miR-155 in breast cancer.
    Wang J; Wu J
    Front Biosci (Landmark Ed); 2012 Jun; 17(6):2350-5. PubMed ID: 22652783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated MicroRNA-mRNA Profiling Identifies Oncostatin M as a Marker of Mesenchymal-Like ER-Negative/HER2-Negative Breast Cancer.
    Bottai G; Diao L; Baggerly KA; Paladini L; Győrffy B; Raschioni C; Pusztai L; Calin GA; Santarpia L
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration.
    Terkelsen T; Russo F; Gromov P; Haakensen VD; Brunak S; Gromova I; Krogh A; Papaleo E
    Breast Cancer Res; 2020 Jun; 22(1):73. PubMed ID: 32605588
    [TBL] [Abstract][Full Text] [Related]  

  • 9. mRNA expression profiles show differential regulatory effects of microRNAs between estrogen receptor-positive and estrogen receptor-negative breast cancer.
    Cheng C; Fu X; Alves P; Gerstein M
    Genome Biol; 2009; 10(9):R90. PubMed ID: 19723326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA expression and gene regulation drive breast cancer progression and metastasis in PyMT mice.
    Nogales-Cadenas R; Cai Y; Lin JR; Zhang Q; Zhang W; Montagna C; Zhang ZD
    Breast Cancer Res; 2016 Jul; 18(1):75. PubMed ID: 27449149
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPER1 and microRNA: Two Players in Breast Cancer Progression.
    Vivacqua A
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA signatures predict oestrogen receptor, progesterone receptor and HER2/neu receptor status in breast cancer.
    Lowery AJ; Miller N; Devaney A; McNeill RE; Davoren PA; Lemetre C; Benes V; Schmidt S; Blake J; Ball G; Kerin MJ
    Breast Cancer Res; 2009; 11(3):R27. PubMed ID: 19432961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular pathogenesis of breast cancer: impact of miR-99a-5p and miR-99a-3p regulation on oncogenic genes.
    Shinden Y; Hirashima T; Nohata N; Toda H; Okada R; Asai S; Tanaka T; Hozaka Y; Ohtsuka T; Kijima Y; Seki N
    J Hum Genet; 2021 May; 66(5):519-534. PubMed ID: 33177704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miRNA expression profiling of hereditary breast tumors from BRCA1- and BRCA2-germline mutation carriers in Brazil.
    Pessôa-Pereira D; Evangelista AF; Causin RL; da Costa Vieira RA; Abrahão-Machado LF; Santana IVV; da Silva VD; de Souza KCB; de Oliveira-Silva RJ; Fernandes GC; Reis RM; Palmero EI; Marques MMC
    BMC Cancer; 2020 Feb; 20(1):143. PubMed ID: 32087690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA regulation of progesterone receptor in breast cancer.
    Gilam A; Shai A; Ashkenazi I; Sarid LA; Drobot A; Bickel A; Shomron N
    Oncotarget; 2017 Apr; 8(16):25963-25976. PubMed ID: 28404930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA expression and function in cancer.
    Garzon R; Fabbri M; Cimmino A; Calin GA; Croce CM
    Trends Mol Med; 2006 Dec; 12(12):580-7. PubMed ID: 17071139
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.
    Vos S; Vesuna F; Raman V; van Diest PJ; van der Groep P
    Oncotarget; 2015 Oct; 6(31):32115-37. PubMed ID: 26378051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNAs in breast cancer: oncogene and tumor suppressors with clinical potential.
    Wang W; Luo YP
    J Zhejiang Univ Sci B; 2015 Jan; 16(1):18-31. PubMed ID: 25559952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating microRNA-based screening tool for breast cancer.
    Frères P; Wenric S; Boukerroucha M; Fasquelle C; Thiry J; Bovy N; Struman I; Geurts P; Collignon J; Schroeder H; Kridelka F; Lifrange E; Jossa V; Bours V; Josse C; Jerusalem G
    Oncotarget; 2016 Feb; 7(5):5416-28. PubMed ID: 26734993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA-34b as a tumor suppressor in estrogen-dependent growth of breast cancer cells.
    Lee YM; Lee JY; Ho CC; Hong QS; Yu SL; Tzeng CR; Yang PC; Chen HW
    Breast Cancer Res; 2011; 13(6):R116. PubMed ID: 22113133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.